文献速递白血病

高灵敏度多色流式B-ALL微小残留病检测中的模拟细胞与伪影

Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease.
PubMed 文献 · Br J Haematol · 2021-09-02

该研究基于301例儿童共441份B-ALL微小残留病(BMRD)样本,描述了6类持续存在的低水平细胞群,其免疫表型可模拟异常B-ALL原始细胞。研究提供了这些模拟细胞的比例、完整免疫表型及识别线索,强调认识这些模拟细胞对高灵敏度MFC-BMRD准确判读至关重要。

要点

  • 高灵敏度MFC-BMRD检测中需警惕6类低水平模拟细胞群。
  • 模拟细胞包括pDC、过渡型B细胞、NK细胞、间充质干细胞等。
  • 掌握模拟细胞的免疫表型与识别线索可避免误判。

核心结论

  • 高灵敏度MFC-BMRD分析中识别模拟细胞与伪影是准确判读的关键。

研究设计与样本

  • 回顾性分析301例儿童共441份BMRD样本的多色流式检测结果。

主要发现

  • 发现6类持续存在的低水平细胞群可免疫表型模拟异常B-ALL原始细胞。
  • 模拟细胞包括CD19+CD123+浆细胞样树突状细胞、CD10+过渡型B细胞、CD19+NK细胞、CD73bright/CD10+间充质干细胞、CD73bright/CD34+内皮细胞及CD34+CD38dim至阴性/CD10-/CD20bright/CD45bright成熟B细胞亚群。
  • 研究提供了各模拟细胞群的比例、完整免疫表型及实用识别线索。

临床怎么用

  • 在高灵敏度MFC-BMRD判读中应结合完整免疫表型识别模拟细胞,避免将低水平模拟细胞误判为残留白血病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

High-sensitivity multicolour flow cytometry (MFC)-based B-lymphoblastic leukaemia (B-ALL) measurable residual disease (BMRD) assay is increasingly being used in clinical practice. Herein, we describe six consistently present low-level populations immunophenotypically mimicking abnormal B-ALL blasts in 441 BMRD samples from 301 children. These included CD19+ CD123+ plasmacytoid dendritic cells differentiating from lymphoid precursors, CD10+ transitional B cells with CD10+ /CD38dim-to-negative/CD20bright/CD45bright phenotype, CD19+ natural killer (NK) cells, CD73bright/CD10+ mesenchymal stromal/stem cells, CD73bright/CD34+ endothelial cells, and a CD34+ CD38dim-to-negative/CD10- /CD20bright/CD45bright subset of mature B cells. We provide the proportions, comprehensive immunophenotype, and practical clues for proper identification of these low-level populations. Knowledge regarding the presence and immunophenotype of these mimics is essential for accurate interpretation in high-sensitivity MFC-BMRD analysis.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Chatterjee G, Sriram H, Ghogale S, et al. Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual disease. Br J Haematol. 2021. PMID: 34476808. doi:10.1111/bjh.17801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。